Previous research has reported that down-regulated SPARCL1 occurred frequently in most human cancers and emerging publications have reported the potential role of SPARCL1 to reduce cell proliferation and inhibit DNA synthesis [8–10]. Here, SPARCL1 is linked to cancer.